DPYD and colorectal cancer: Another mechanism of DPD activity variation and changes in risk induced by fluoropyrimidines is thorough transcriptional regulation of DPYD. Epigenetic alterations may affect DPYD expression, as shown in the RKO colorectal cancer cell line [19].